Personal Genome Diagnostics Inc:製品パイプライン分析

GlobalDataが発行した調査報告書(DATA8013773)
◆英語タイトル:Personal Genome Diagnostics Inc - Product Pipeline Analysis, 2017 Update
◆商品コード:DATA8013773
◆発行会社(リサーチ会社):GlobalData
◆発行日:2017年10月13日
◆ページ数:28
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD1,500 ⇒換算¥222,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD2,250 ⇒換算¥333,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

Summary
Personal Genome Diagnostics Inc (PGD) is a genomic solution provider. The company develops next-generation sequencing and proprietary algorithms to identify alterations in complex cancer genomes. It provides a portfolio of regulated tissue-based and liquid biopsy genomic products for laboratories. PGD offers custom solutions such as cancer whole genome analysis, cancer genome germline analysis, cancer bioinformatic analysis and ctDNA analyses, among others. The company caters its products and services to academics, biotechnology and pharmaceutical companies, and contract research organizations. PGD is headquartered in Baltimore, Maryland, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Personal Genome Diagnostics Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Personal Genome Diagnostics Inc Company Overview 4
Personal Genome Diagnostics Inc Company Snapshot 4
Personal Genome Diagnostics Inc Pipeline Products and Ongoing Clinical Trials Overview 5
Personal Genome Diagnostics Inc – Pipeline Analysis Overview 7
Personal Genome Diagnostics Inc – Key Facts 7
Personal Genome Diagnostics Inc – Major Products and Services 8
Personal Genome Diagnostics Inc Pipeline Products by Development Stage 9
Personal Genome Diagnostics Inc Pipeline Products Overview 11
MutatorDETECT Assay 11
MutatorDETECT Assay Product Overview 11
PGDx Plasma Based Diagnostic Kit 12
PGDx Plasma Based Diagnostic Kit Product Overview 12
PGDx Tissue Based Diagnostic Kit 13
PGDx Tissue Based Diagnostic Kit Product Overview 13
PlasmaSelect-R Liquid Biopsy Test – CLIA 14
PlasmaSelect-R Liquid Biopsy Test – CLIA Product Overview 14
Personal Genome Diagnostics Inc – Key Competitors 15
Personal Genome Diagnostics Inc – Key Employees 16
Personal Genome Diagnostics Inc – Locations And Subsidiaries 17
Head Office 17
Recent Developments 18
Personal Genome Diagnostics Inc, Recent Developments 18
Jun 14, 2017: Personal Genome Diagnostics Awarded Department of Veterans Affairs Contract for Its PlasmaSELECT Liquid Biopsy Cancer Profiling Assay 18
Jun 02, 2017: Personal Genome Diagnostics Highlights its Patent-Pending Microsatellite Instability Testing Technology as FDA Approves Keytruda for MSI Tumors 18
Mar 30, 2017: Personal Genome Diagnostics Announces AACR Annual Meeting 2017 Presentations and Awards 19
Mar 28, 2017: Personal Genome Diagnostics’ Expanded PlasmaSELECT 64 Is First Liquid Biopsy Pan-Cancer Profiling Panel to Include MSI Analyses for Immuno-Oncology 20
Mar 22, 2017: Personal Genome Diagnostics Announces Expanded Cancer Testing Contract with U.S. Department of Veteran Affairs 21
Feb 01, 2017: Personal Genome Diagnostics Awarded National Cancer Institute Contract to Develop Novel Diagnostic for Immuno-Oncology Drugs 21
Jan 17, 2017: Personal Genome Diagnostics Adds James Lewis as Senior Vice President of Corporate Development 22
Jan 04, 2017: Personal Genome Diagnostics ImmunoSELECT Technology Demonstrates How Resistance to Checkpoint Blockade Therapy Evolves in Cancer Discovery Study 23
Dec 19, 2016: Personal Genome Diagnostics Launches CancerSELECT 125 Test for Pan-Cancer Tumor Profiling 23
Nov 29, 2016: Veteran Regulatory Expert Maria Chan Joins Personal Genome Diagnostics 24
Appendix 25
Methodology 25
About GlobalData 27
Contact Us 27
Disclaimer 28

List of Tables
Personal Genome Diagnostics Inc Pipeline Products and Ongoing Clinical Trials Overview 5
Personal Genome Diagnostics Inc Pipeline Products by Equipment Type 5
Personal Genome Diagnostics Inc Pipeline Products by Indication 6
Personal Genome Diagnostics Inc, Key Facts 7
Personal Genome Diagnostics Inc, Major Products and Services 8
Personal Genome Diagnostics Inc Number of Pipeline Products by Development Stage 9
Personal Genome Diagnostics Inc Pipeline Products Summary by Development Stage 10
MutatorDETECT Assay - Product Status 11
MutatorDETECT Assay - Product Description 11
PGDx Plasma Based Diagnostic Kit - Product Status 12
PGDx Plasma Based Diagnostic Kit - Product Description 12
PGDx Tissue Based Diagnostic Kit - Product Status 13
PGDx Tissue Based Diagnostic Kit - Product Description 13
PlasmaSelect-R Liquid Biopsy Test - CLIA - Product Status 14
PlasmaSelect-R Liquid Biopsy Test - CLIA - Product Description 14
Personal Genome Diagnostics Inc, Key Employees 16
Glossary 26

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ Personal Genome Diagnostics Inc:製品パイプライン分析(Personal Genome Diagnostics Inc - Product Pipeline Analysis, 2017 Update)]についてメールでお問い合わせはこちらでお願いします。

◆H&Iグローバルリサーチのお客様(例)◆